PRA Health Sciences (PRAH) PT Raised to $93 at KeyBanc

Go back to PRA Health Sciences (PRAH) PT Raised to $93 at KeyBanc

PRA Health Sciences (PRAH) PT Raised to $101 at SunTrust Robinson Humphrey

October 30, 2017 5:34 AM EDT

SunTrust Robinson Humphrey raised its price target on PRA Health Sciences (NASDAQ: PRAH) to $101.00 (from $94.00) while maintaining a Buy rating.

Analyst Sandy Draper believes investors are under-appreciating the equity as the management team continues to delivery results beyond expectations.

... More

PRA Health Sciences (PRAH) PT Raised to $91 at Baird

October 26, 2017 8:31 AM EDT

Baird raised its price target on PRA Health Sciences (NASDAQ: PRAH) to $91.00 (from $88.00) while maintaining a Outperform rating.

... More